Denmark
# |
Name |
EPS (Diluted) |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
USD 9.77
|
Dec. 31, 2023 | USD 216.88 | 1.28% |
|
Denmark |
|
2 |
USD -0.00
|
Dec. 31, 2023 | USD 0.64 | 1.38% |
|
Denmark |
|
3 |
USD -0.13
|
Dec. 31, 2023 | USD 0.57 | 1.47% |
|
Denmark |
|
4 |
USD -0.48
|
Dec. 31, 2023 | USD 3.98 | 0.01% |
|
Denmark |
|
5 |
USD -0.52
|
Dec. 31, 2023 | USD 1.93 | -6.19% |
|
Denmark |
The Clinical Trials company in Denmark with the highest EPS (Diluted) is Genmab A/S (Copenhagen Stock Exchange: GMAB.CO) at USD 9.77.
The Clinical Trials company in Denmark with the lowest EPS (Diluted) is ViroGates A/S (Copenhagen Stock Exchange: VIRO.CO) at USD -0.52.
The top 10 Clinical Trials companies in Denmark by EPS (Diluted) are Genmab A/S, Initiator Pharma A/S, Saniona AB (publ), FluoGuide A/S and ViroGates A/S.
The bottom 10 Clinical Trials companies in Denmark by EPS (Diluted) are ViroGates A/S, FluoGuide A/S, Saniona AB (publ), Initiator Pharma A/S and Genmab A/S.